Corvus Pharma reports encouraging data for its eczema drug soquelitinib, showing strong skin improvement and no serious ...

Millions of Brits with eczema are almost twice as likely to suffer agonising eye and bowel conditions, research suggests.

Biotech stock Corvus Pharmaceuticals catapulted to a nine-year high Tuesday on promising results in eczema treatment.

Corvus Pharma (CRVS) stock surges as the company plans a Phase 2 trial for its lead asset against eczema following ...

Rising misuse of unregulated creams and delays in treatment are driving more severe eczema cases in Malaysia, specialists ...

Californian biopharma Corvus Pharmaceuticals has announced positive results from cohort four of the randomized, blinded, ...

The phase 3 trial DELTA CARE 1 will recruit up to 652 adult patients with lichen sclerosus (LS) to investigate the efficacy ...

Winters are known to worsen symptoms of eczema due to dropping temperatures.It is believed that around 8 million people in ...

Naomi, who lives with suspected severe eczema, has long endured a complex and persistent skin condition that has deeply affected her quality of life.

Experts review emerging contact allergens found in consumer products and medical implants, highlighting new diagnostic ...

Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that affects millions of children and adults. It often causes itching, redness, dryness, flaking, and sometimes ...